ELAVL1 and prostate cancer: Besides, m6A modification mediates the biogenesis of circDDIT4, which binds to ELAVL1 and acts as an RBP sponge to downregulate the expression of ELAVL1 target mRNAs, including ANO7, thus exerting a tumor suppressor effect on the progression of prostate cancer [79].